Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BPO and Electrocautery for C. acnes in Shoulder Arthroplasty
NCT05676411Phase 4Withdrawn
- Sponsor
- University of Missouri
- Start
- Jun 2024
- Primary completion
- Jul 2025
- Modality
- Transdermal Patches, Hydrogel Systems, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of benzoyl peroxide + sulfur in prosthetic joint infection (PJI) (2 arms), sponsored by University of Missouri. Primary endpoint: Late dermis Cutibacterium acnes culture rates at 14 days. Planned start Jun 2024; status: withdrawn.
02
Drugs
benzoyl peroxide + sulfur
03
Conditions
prosthetic joint infection (PJI)
Beyond the preview
Go deeper on NCT05676411.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05676411.